Sherwin Kb Sy

22PUBLICATIONS
24CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Medical bacteriologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 03, 2026
FDA Gene Therapy Approvals (1998-2025): Current Status, Regulatory Evolution, and Future Directions.

|Feb 11, 2026
Leveraging Model-Informed Drug Development to Predict Asciminib Efficacy in Second-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase.

Sherwin K B Sy, Deok Yong Yoon, Yiqun Yang

|Jul 30, 2025
The Application of Quantitative 1H-NMR for the Determination of Melatonin and Vitamin B6 in Commercial Melatonin Products.

Xinyu Gao, Jiahao Niu, Zhengjian Xiao

|Feb 11, 2025
The impact of aztreonam-clavulanic acid exposure on gene expression and mutant selection using a multidrug-resistant E. coli.

Tongtong Lin, Jiayuan Zhang, Shuo Diao

|Dec 31, 2024
Population modelling of nilotinib exposure vs. longitudinal BCR::ABL1 response in patients with chronic phase chronic myeloid leukaemia using a semimechanistic disease model.

Sherwin K B Sy, Deok Yong Yoon, Christelle Darstein

|Oct 29, 2024
Clinical Pharmacology of Asciminib: A Review.

Matthias Hoch, Felix Huth, Paul William Manley

Pageof 4

Frequent Collaborators

4 joint publications

Francois Pierre Combes

4 joint publications

Mingming Yu

3 joint publications

Ying Fei Li

2 joint publications

Frederico Severino Martins